Date of Presentation
5-2-2024 12:00 AM
College
Rowan-Virtua School of Osteopathic Medicine
Poster Abstract
Cold Agglutinin disease (CAD) also known as Cold Autoimmune Hemolytic Anemia (AIHA) is a form of autoimmune hemolytic anemia wherein cold agglutinins (IgM autoantibodies against red blood cell (RBC) antigens) bind during cold temperatures causing clinical symptoms related to RBC agglutination resulting to hemolytic anemia. Clinicians should recognize that Cold Agglutinin disease can be secondary to an underlying pathology such as COVID-19. Here we describe an unusual case of Cold Agglutinin Autoimmune Hemolytic Anemia which was diagnosed in the Emergency Department with the presence of COVID-19 and with a hospital course complicated by acute deep vein thrombosis (DVT) and bilateral pulmonary embolisms (PE’s).
Keywords
Cold Agglutinin Disease, Autoimmune Hemolytic Anemia, COVID-19
Disciplines
Emergency Medicine | Hematology | Hemic and Lymphatic Diseases | Immune System Diseases | Medicine and Health Sciences | Pathological Conditions, Signs and Symptoms | Virus Diseases
Document Type
Poster
Included in
Emergency Medicine Commons, Hematology Commons, Hemic and Lymphatic Diseases Commons, Immune System Diseases Commons, Pathological Conditions, Signs and Symptoms Commons, Virus Diseases Commons
Chilling Complications: A Case of COVID-Associated Cold Autoimmune Hemolytic Anemia (AIHA)
Cold Agglutinin disease (CAD) also known as Cold Autoimmune Hemolytic Anemia (AIHA) is a form of autoimmune hemolytic anemia wherein cold agglutinins (IgM autoantibodies against red blood cell (RBC) antigens) bind during cold temperatures causing clinical symptoms related to RBC agglutination resulting to hemolytic anemia. Clinicians should recognize that Cold Agglutinin disease can be secondary to an underlying pathology such as COVID-19. Here we describe an unusual case of Cold Agglutinin Autoimmune Hemolytic Anemia which was diagnosed in the Emergency Department with the presence of COVID-19 and with a hospital course complicated by acute deep vein thrombosis (DVT) and bilateral pulmonary embolisms (PE’s).